ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium

Cancer Causes and Control

Volumn 23, Issue 11, 2012, Pages 1805-1810

  Poole, Elizabeth M ^a,b   Gates, Margaret A ^a,b,c   High, Brigit A ^a,d   Chanock, Stephen J ^e   Cramer, Daniel W ^a   Cunningham, Julie M ^f   Fridley, Brooke L ^f   Gayther, Simon A ^g   Goode, Ellen L ^f   Iversen, Edwin S ^h   Lissowska, Jolanta ⁱ   Weber, Rachel T Palmieri ^j   Pharoah, Paul D P ^k   Phelan, Catherine M ^l   Ramus, Susan J ^g   Schildkraut, Joellen M ^j,m   Sutphen, Rebecca ⁿ   Tsai, Ya Yu ^l   Tyrer, Jonathan ^a   Vierkant, Robert A ^f   Wentzensen, Nicolas ^e   Yang, Hannah P ^e   Terry, Kathryn L ^k   Tworoger, Shelley S ^a,b   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d AMHERST COLLEGE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Mayo Clinic College of Medicine   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h Duke University   (United States)

ⁱ INSTITUTE OF ONCOLOGY   (Poland)

^j DUKE UNIVERSITY MEDICAL CENTER   (United States)

^k UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^l H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^m DUKE CANCER INSTITUTE   (United States)

ⁿ UNIVERSITY OF SOUTH FLORIDA   (United States)

more..

Author keywords

ABO blood group; Genetic epidemiology; Ovarian cancer; Ovarian Cancer Association Consortium (OCAC)

Indexed keywords

ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; CALCULATION; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENOTYPE; HEALTH CARE ORGANIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT;

ABO BLOOD-GROUP SYSTEM; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84867999746     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0059-y     Document Type: Article

References (19)

1. American Cancer Society (2010) Cancer facts and figures 2010. American Cancer Society, Atlanta
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893-2917
3. Bjorkholm E (1984) Blood group distribution in women with ovarian cancer. Int J Epidemiol 13:15-17 (Pubitemid 14162839)
4. Henderson J, Seagroatt V, Goldacre M (1993) Ovarian cancer and ABO blood groups. J Epidemiol Community Health 47:287-289 (Pubitemid 23256202)
5. Osborne RH, Degeorge FV (1963) The Abo blood groups in neoplastic disease of the ovary. Am J Hum Genet 15:380-388
6. Vogel F (1970) Controversy in human genetics. ABO blood groups and disease. Am J Hum Genet 22:464-475
7. Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS (2011) ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 128:482-486
8. Daniels G (2009) The molecular genetics of blood group polymorphism. Hum Genet 126:729-742
9. Goode EL, Chenevix-Trench G, Song H et al (2010) A genomewide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 42:874-879
10. Pearce CL, Near AM, Van Den Berg DJ et al (2009) Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer 100:412-420
11. Terry KL, Tworoger SS, Goode EL et al (2010) MTHFR polymorphisms in relation to ovarian cancer risk. Gynecol Oncol 119:319-324
12. Pare G, Chasman DI, Kellogg M et al (2008) Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 4:e1000118
13. Wolpin BM, Kraft P, Xu M et al (2010) Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 19:3140-3149
14. Song H, Ramus SJ, Tyrer J et al (2009) A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 41:996-1000
15. Garratty G, Glynn SA, McEntire R (2004) ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States. Transfusion 44:703-706 (Pubitemid 38608247)
16. Wolpin BM, Kraft P, Gross M et al (2010) Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 70:1015-1023
17. Barbalic M, Dupuis J, Dehghan A et al (2010) Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 19:1863-1872
18. Paterson AD, Lopes-Virella MF, Waggott D et al (2009) Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 29:1958-1967
19. Qi L, Cornelis MC, Kraft P et al (2010) Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 19:1856-1862